Vanguard Capital Wealth Advisors
BIIB icon

Vanguard Capital Wealth Advisors’s Biogen BIIB Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,300
Closed -$533K – 123
2024
Q2 		$533K Hold
2,300
– – 0.36% 59
2024
Q1 		$496K Hold
2,300
– – 0.35% 66
2023
Q4 		$595K Hold
2,300
– – 0.48% 42
2023
Q3 		$591K Hold
2,300
– – 0.55% 44
2023
Q2 		$655K Hold
2,300
– – 0.59% 35
2023
Q1 		$639K Hold
2,300
– – 0.64% 40
2022
Q4 		$637K Sell
2,300
-50
-2% -$14.1K 0.74% 36
2022
Q3 		$627K Hold
2,350
– – 0.76% 34
2022
Q2 		$479K Hold
2,350
– – 0.54% 51
2022
Q1 		$494K Sell
2,350
-100
-4% -$21.7K 0.35% 72
2021
Q4 		$587K Buy
2,450
+100
+4% +$25.7K 0.42% 60
2021
Q3 		$665K Sell
2,350
-350
-13% -$115K 0.45% 56
2021
Q2 		$934K Buy
2,700
+100
+4% +$30.3K 0.71% 38
2021
Q1 		$697K Hold
2,600
– – 0.59% 44
2020
Q4 		$633K Buy
+2,600
New +$671K 0.58% 43
2020
Q2 		$682K Buy
+2,550
New +$767K 0.8% 35
2019
Q4 		$712K Hold
2,400
– – 0.74% 34
2019
Q3 		$558K Hold
2,400
– – 0.65% 47
2019
Q2 		$561K Sell
2,400
-134
-5% -$30.9K 0.68% 49
2019
Q1 		$598K Buy
2,534
+84
+3% +$26.5K 0.75% 41
2018
Q4 		$737K Hold
2,450
– – 1.1% 25
2018
Q3 		$865K Hold
2,450
– – 0.99% 25
2018
Q2 		$711K Hold
2,450
– – 0.94% 35
2018
Q1 		$666K Hold
2,450
– – 0.88% 39
2017
Q4 		$780K Buy
+2,450
New +$786K 0.98% 33

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Wealth Advisors's BIIB Position: Q3 2024 in Review

Vanguard Capital Wealth Advisors sold out of Biogen (BIIB) in Q3 2024, closing a stake of 2,300 shares — an estimated $533K sold.

Vanguard Capital Wealth Advisors first reported a position in BIIB in Q4 2017 and held it in 25 quarters. The position peaked at $934K in Q2 2021. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Vanguard Capital Wealth Advisors reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 2,300 Biogen shares in Q3 2024, an estimated $533K.
  • Vanguard Capital Wealth Advisors first reported a position in Biogen in Q4 2017 and held it in 25 quarters.
  • Vanguard Capital Wealth Advisors's Biogen position peaked at $934K in Q2 2021.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.